NEVRO CORP. Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities
NEVRO CORP. reported Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther · last filed 2023-11-01
- NEVRO CORP. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- NEVRO CORP. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2022-09-30 was $1.30M.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 3 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 9 month |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 |
| 2022-09-30 | $1.30M 10-Q · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 |